A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Knauer, Carolin ^a   Knauer, Katharina ^a   Müller, Susanne ^a   Ludolph, Albert C ^a   Bengel, Dietmar ^b   Müller, Hans P ^a   Huber, Roman ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Oberschwabenklinik ^*  (Germany)

Author keywords

Biochemical marker; Brain natriuretic peptide; D dimers; Matrix metalloproteinase 9; Stroke

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; D DIMER; GELATINASE B; PROTEIN S100B; BIOLOGICAL MARKER; NERVE PROTEIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHEMICAL PARAMETERS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTI MARKER INDEX; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; PROSPECTIVE STUDY; ADOLESCENT; BLOOD; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; EVALUATION; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; IMMUNOASSAY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE; YOUNG ADULT;

EID: 84857927094     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-14     Document Type: Article

References (26)

1. Weimar C, Kraywinkel K, Maschke M, Diener HC, German Stroke SC. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc Dis 2006, 22(5-6):429-431. 10.1159/000094995, 16912477.
2. Hacke W, Donnan G, Fieschi C, Kaste M. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363(9411):768-774.
3. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, von KR, Donnan G, Heiss WD, Wahlgren NG, Spranger M, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. [Review] [12 refs]. Neurol 1999, 53(7 Suppl 4):S3-14.
4. de Camargo ECS, Koroshetz WJ. Neuroimaging of ischemia and infarction. [Review] [97 refs]. NeuroRx 2005, 2(2):265-276. 10.1602/neurorx.2.2.265, 1064991, 15897950.
5. Mejdoubi M, Calviere L, Dumas H. [Value of CT perfusion for the diagnosis of early middle cerebral artery stroke]. J Radiol 2010, 91(5 Pt 1):555-560.
6. Davis DP, Robertson T, Imbesi SG, Davis DP, Robertson T, Imbesi SG. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 2006, 31(3):269-277. 10.1016/j.jemermed.2005.10.003, 16982360.
7. von Kummer R, Dzialowski I, von Kummer R, Dzialowski I. MRI versus CT in acute stroke. Lancet 2007, 369(9570):1341-1342. author reply 1342.
8. Brazzelli M, Sandercock PA, Chappell FM, Celani MG, Righetti E, Arestis N, Wardlaw JM, Deeks JJ, Brazzelli M, Sandercock PA, et al. Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptoms. Cochrane Database Syst Rev 2009, (4):CD007424.
9. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24(1):35-41. 10.1161/01.STR.24.1.35, 7678184.
10. Vanni S, Polidori G, Pepe G, Chiarlone M, Albani A, Pagnanelli A, Grifoni S. Use of Biomarkers in Triage of Patients with Suspected Stroke. J Emerg Med 2009,
11. Prabhakaran S, Chong JY, Sacco RL, Prabhakaran S, Chong JY, Sacco RL. Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol 2007, 64(8):1105-1109. 10.1001/archneur.64.8.1105, 17698700.
12. Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, Hershey LA, Qazi KJ. Buffalo Metropolitan A, Erie County Stroke Study G: Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurol 2005, 64(12):2115-2120.
13. Kim MH, Kang SY, Kim MC, Lee WI, Kim MH, Kang SY, Kim MC, Lee WI. Plasma biomarkers in the diagnosis of acute ischemic stroke. Annals of Clinical & Laboratory Science 2010, 40(4):336-341.
14. Sibon I, Rouanet F, Meissner W, Orgogozo JM. Use of the Triage Stroke Panel in a neurologic emergency service. American Journal of Emergency Medicine 2009, 27(5):558-562. 10.1016/j.ajem.2008.05.001, 19497461.
15. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?. Stroke 2006, 37(1):98-104.
16. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 2000, 31(11):2597-2602. 10.1161/01.STR.31.11.2597, 11062281.
17. Nash DL, Bellolio MF, Stead LG, Nash DL, Bellolio MF, Stead LG. S100 as a marker of acute brain ischemia: a systematic review. Neurocritical Care 2008, 8(2):301-307. 10.1007/s12028-007-9019-x, 17968519.
18. Ramos-Fernandez M, Bellolio MF, Stead LG, Ramos-Fernandez M, Bellolio MF, Stead LG. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. Journal of Stroke & Cerebrovascular Diseases 2011, 20(1):47-54. 10.1016/j.jstrokecerebrovasdis.2009.10.008, 22432110.
19. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A, Quintana M, Palacios ME, Molina CA, varez-Sabin J. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008, 39(8):2280-7. 10.1161/STROKEAHA.107.505354, 18535284.
20. Rodriguez-Yanez M, Castellanos M, Blanco M, Garcia MM, Nombela F, Serena J, Leira R, Lizasoain I, Davalos A, Castillo J. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology 2006, 67(11):1973-1978. 10.1212/01.wnl.0000247064.53130.91, 17159103.
21. Giannakoulas G, Hatzitolios A, Karvounis H, Koliakos G, Charitandi A, Dimitroulas T, Savopoulos C, Tsirogianni E, Louridas G. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 2005, 56(6):723-730. 10.1177/000331970505600610, 16327949.
22. Iltumur K, Karabulut A, Apak I, Aluclu U, Ariturk Z, Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Hear J 2006, 151(5):1115-1122.
23. Tomita H, Metoki N, Saitoh G, Ashitate T, Echizen T, Katoh C, Fukuda M, Yasujima M, Osanai T, Okumura K, et al. Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity. Hypertension Research-Clinical & Experimental 2008, 31(9):1695-1702. 10.1291/hypres.31.1695, 21577138.
24. Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, et al. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 75(12):1040-1047.
25. Kamchatov PR, Ruleva NI, Dugin SF, Buriachkovskaia LI, Chugunov AV, Mikhailova NA, Basse DA. [Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke]. [Russian]. Zhurnal Nevrologii i Psikhiatrii Imeni SSKorsakova 2009, 109(5 Suppl 2):69-72.
26. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR, . Group Nr-PSS Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006, 37(10):2508-13. 10.1161/01.STR.0000242290.01174.9e, 16960091, Group Nr-PSS.